Division of Innovative Cancer Therapy
| Head | TODO Tomoki |
|---|---|
| Location | Second Building 4F |
| Website |
Division of Innovative Cancer Therapy website (Japanese only) |
| Annual Report |
Activities
We have been focusing on the development of innovative cancer treatment, especially with genetically-engineered viruses which can kill the tumor cells without affecting normal cells. G47Δ, a triple-mutated herpes simplex virus type I (HSV-1), exhibits potent therapeutic efficacy with enhanced safety. G47Δ has been used in several clinical trials that are ongoing. We are also seeking next generation therapeutics utilizng G47Δ and patient-derived glioma cell lines to overcome resistance, recurrence and metastasis often seen in the clinical settings.
Member List
-
-
-
-
-
-
KANAYAMA Seisaku Assistant Professor
03-6409-2145
mntanaka-nsu
umin.ac.jp